lx2022
·Code: LX2022
lx2022: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | Phase 1/Phase 2 |
Get deeper analysis on lx2022
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis